Australia cosmetic ingredient regulations
AICIS inventory status is not cosmetic approval and is presented as context only.
- Regulator
- Australian Industrial Chemicals Introduction Scheme
- Source language
- English
- Coverage version
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
Official ingredient records
93 matching recordsLEAD COMPOUNDS
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: LEAD COMPOUNDS except: (a) when included in, or expressly excluded from, Schedule 10; or (b) in preparations for cosmetic use containing 10 mg/kg or less of lead; or (c) in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints/colours or coloured chalks containing 25 mg/kg or less of lead; or (d) in ceramic glazes when labelled with the warning statement: CAUTION – Harmful if swallowed. Do not use on surfaces which contact food or drink; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
LEMONGRASS OIL
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: LEMONGRASS OIL in cosmetic and household cleaning preparations except in preparations containing 5% or less of 3,7-dimethyl-2,6-octadienal.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
MERCAPTAMINE
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: MERCAPTAMINE in cosmetic preparations containing 6% or less of mercaptamine except in preparations containing 1% or less of mercaptamine.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
MERCAPTAMINE
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: MERCAPTAMINE for cosmetic use except: (a) when included in Schedule 5; or (b) in preparations containing 1% or less of mercaptamine.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
MERCAPTOACETIC ACID and its salts, but excluding its derivatives
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: MERCAPTOACETIC ACID and its salts, but excluding its derivatives, in cosmetic preparations containing 20% or less of mercaptoacetic acid or its salts (as mercapturic acid), except in preparations containing 5% or less of mercaptoacetic acid or its salts (as mercapturic acid)
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
MERCAPTOACETIC ACID and its salts, but excluding its derivatives
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: MERCAPTOACETIC ACID and its salts, but excluding its derivatives, in cosmetic preparations except: (a) when included in Schedule 5; or (b) in preparations containing 5% or less of mercaptoacetic acid or its salts (as mercapturic acid).
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
MERCURY
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: MERCURY for cosmetic or therapeutic use except: (a) when separately specified in these Schedules; or (b) in a sealed device which prevents access to the mercury.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
METHENAMINE
CAS 100-97-0 · EC 202-905-8
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: METHENAMINE in cosmetic preparations, except in preparations containing 0.15% or less of methenamine.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
METHYL METHACRYLATE (excluding its derivatives)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: METHYL METHACRYLATE (excluding its derivatives) except: (a) for cosmetic use; or (b) in preparations containing 1% or less of methyl methacrylate as residual monomer in a polymer.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
METHYLCHLOROISOTHIAZOLINONE
CAS 26172-55-4 · EC 247-500-7
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: METHYLCHLOROISOTHIAZOLINONE except: (a) in rinse-off cosmetic preparations or therapeutic goods intended for topical rinse-off application containing 0.0015% or less of methylchloroisothiazolinone and methylisothiazolinone in total; or (b) in other preparations that are not intended for direct application to the skin containing 0.1% or less of methylchloroisothiazolinone and methylisothiazolinone in total.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
METHYLISOTHIAZOLINONE
CAS 2682-20-4 · EC 220-239-6
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: METHYLISOTHIAZOLINONE except: (a) in rinse-off cosmetic preparations or therapeutic goods intended for topical rinse-off application containing 0.0015% or less of methylisothiazolinone; or (b) in other preparations that are not intended for direct application to the skin containing 0.1% or less of methylisothiazolinone
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
MONOBENZONE and alkyl ethers of hydroquinone
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: MONOBENZONE and alkyl ethers of hydroquinone for human therapeutic use or cosmetic use except in cosmetic nail preparations containing 0.02% or less of monobenzone or alkyl ethers of hydroquinone.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
OXALIC ACID
CAS 144-62-7 · EC 205-634-3
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: OXALIC ACID except (a) in dental care preparations, including mouthwashes, containing 3% or less of soluble salts of oxalic acid; or (b) its insoluble salts.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
PALMITOYLETHANOLAMIDE (excluding derivatives)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: PALMITOYLETHANOLAMIDE (excluding derivatives) except: (a) in preparations for therapeutic use; or (b) in preparations for dermal cosmetic use containing 1% or less of palmitoylethanolamide.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
PARAFORMALDEHYDE (excluding its derivatives)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 2.
Conditions: PARAFORMALDEHYDE (excluding its derivatives) for human therapeutic use except: (a) in oral hygiene preparations containing 0.1% or less of free formaldehyde; or (b) in other preparations containing 0.2% or less of free formaldehyde.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 2 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
PARAFORMALDEHYDE (excluding its derivatives)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: PARAFORMALDEHYDE (excluding its derivatives) in preparations containing 0.05% or more of free formaldehyde except: (a) for human therapeutic use; or (b) in oral hygiene preparations; or (c) in nail hardener cosmetic preparations containing 5% or more of free formaldehyde; or (d) in nail hardener cosmetic preparations containing 0.2% or less of free formaldehyde when labelled with the statement: PROTECT CUTICLES WITH GREASE OR OIL; or (e) in all other cosmetic preparations; or (f) in other preparations containing 0.2% or less of free formaldehyde when labelled with the warning statement: CONTAINS FORMALDEHYDE.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
PHENYL METHYL PYRAZOLONE
CAS 89-25-8 · EC 201-891-0
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: PHENYL METHYL PYRAZOLONE except when used in hair dye and eyebrow/eyelash preparations at a concentration of 0.25% or less after mixing for use when the immediate container and primary pack are labelled with warning statements to the following effect:
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
PHENYLENEDIAMINES including alkylated, arylated, halogenated and nitro derivatives not elsewhere specified
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: PHENYLENEDIAMINES including alkylated, arylated, halogenated and nitro derivatives not elsewhere specified in these Schedules: (a) in preparations packed and labelled for photographic purposes; or (b) in preparations packed and labelled for testing water except tablets containing 10 mg or less of diethyl-para-phenylenediamine or dimethyl-para-phenylenediamine in opaque strip packaging provided the directions for use include the statement, “Do not discard testing solutions into the pool”; or (c) in hair dye preparations except when the immediate container and primary pack are labelled with the following statements: (i) KEEP OUT OF REACH OF CHILDREN; and (ii) WARNING ‒ This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye; written in letters not less than 1.5 mm in height; or (d) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement: WARNING ‒ This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
PICRAMIC ACID including its salts (excluding other derivatives)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: PICRAMIC ACID including its salts (excluding other derivatives) except when used in hair dye products at a concentration of 0.6% or less of picramic acid after mixing for use when the immediate container and primary pack are labelled with the following statements: (a) KEEP OUT OF REACH OF CHILDREN; and (b) WARNING ‒ This product contains ingredients which may cause skin allergy to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
POLIHEXANIDE
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: POLIHEXANIDE except: (a) in cosmetic preparations containing 0.3% or less of polihexanide; or
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
POLYACRYLAMIDE
CAS 9003-05-8
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: POLYACRYLAMIDE in preparations for injection or implantation: (a) for tissue augmentation; or (b) for cosmetic use; or (c) for veterinary use.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
POLYCAPROLACTONE
CAS 24980-41-4
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: POLYCAPROLACTONE in preparations for injection or implantation: (a) for tissue augmentation; or (b) for cosmetic use.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
POLYLACTIC ACID
CAS 9051-89-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: POLYLACTIC ACID in preparations for injection or implantation: (a) for tissue augmentation; or (b) for cosmetic use.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
POTASSIUM AZELOYL DIGLYCINATE
CAS 477773-67-4 · EC 470-270-6
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: POTASSIUM AZELOYL DIGLYCINATE except in preparations for cosmetic use containing 1% or less of potassium azeloyl diglycinate.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
QUININE
CAS 130-95-0 · EC 205-003-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: QUININE in cosmetic preparations except: (a) in rinse-off hair preparations containing 0.5% or less of quinine calculated as free base; or (b) in leave-on hair preparations containing 0.2% or less of quinine calculated as free base.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
RESORCINOL
CAS 108-46-3 · EC 203-585-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: RESORCINOL except: (a) in preparations for human therapeutic use; or (b) in oxidative hair dye preparations containing 1.25% or less of resorcinol after mixing for use when the immediate container and primary pack are labelled with the following statements: (i) KEEP OUT OF REACH OF CHILDREN; and (ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye; written in letters not less than 1.5 mm in height; or (c) in oxidative eyelash and eyebrow dye preparations containing 1.25% or less of resorcinol after mixing for use when the immediate container and primary pack are labelled with the following statements: (i) KEEP OUT OF REACH OF CHILDREN; and (ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use; written in letters not less than 1.5 mm in height; or (d) in hair lotions/shampoo products containing 0.5% or less of resorcinol when the immediate container and primary pack are labelled with the following statement: WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
SODIUM POLYSTYRENE SULPHONATE
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: SODIUM POLYSTYRENE SULPHONATE in preparations for cosmetic use except in preparations containing 10% or less of sodium polystyrene sulphonate.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
SODIUM STANNATE
CAS 12058-66-1 · EC 235-030-5
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: SODIUM STANNATE except in preparations for cosmetic use containing 1% or less of sodium stannate.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
SYMPHYTUM spp. (Comfrey)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: SYMPHYTUM spp. (Comfrey) for dermal therapeutic or dermal cosmetic use.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
TOLUENEDIAMINES not elsewhere specified
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: TOLUENEDIAMINES not elsewhere specified in these Schedules: (a) in hair dye preparations except when the immediate container and primary pack are labelled with the following statements: (i) KEEP OUT OF REACH OF CHILDREN; and (ii) WARNING – This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye; written in letters not less than 1.5 mm in height; or (b) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement: WARNING – This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use; written in letters not less than 1.5 mm in height; or (c) in nail polish preparations containing 2,5-toluenediamine except when labelled “avoid contact with skin”.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
TRANEXAMIC ACID
CAS 1197-18-8 · EC 214-818-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: TRANEXAMIC ACID except in preparations containing 3% or less of tranexamic acid for dermal cosmetic use.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
TRICLOSAN
CAS 3380-34-5 · EC 222-182-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: TRICLOSAN in cosmetic preparations for human use containing more than 0.3% of triclosan.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
TROLAMINE
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: TROLAMINE when in preparations for tattoo removal.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
VINYL ACETATE MONOMER (excluding its derivatives)
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: VINYL ACETATE MONOMER (excluding its derivatives) except: (a) in preparations for therapeutic use; or (b) in cosmetic preparations containing 0.01% or less of vinyl acetate as residual monomer in a polymer; or (c) in other preparations containing 1% or less of vinyl acetate.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
VITAMIN A
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 4.
Conditions: VITAMIN A for human therapeutic or cosmetic use except: (a) in preparations for topical use containing 1% or less of Vitamin A; or (b) in preparations for internal use containing 3000 micrograms retinol equivalents or less of Vitamin A per daily dose; or (c) in preparations for parenteral nutrition replacement.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 4 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
ZINC LACTATE
CAS 16039-53-5 · EC 240-178-9
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: ZINC LACTATE in toothpaste except in toothpaste preparations containing 2.5% or less of zinc lactate and labelled with the statement: Not recommended for children under twelve years of age.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
m-AMINOPHENOL
CAS 591-27-5 · EC 209-711-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: m-AMINOPHENOL except when used in hair dye and eyebrow/eyelash preparations at a concentration of 1.2% or less of m-aminophenol after mixing for use when the immediate container and primary pack are labelled with the following statements: (a) KEEP OUT OF REACH OF CHILDREN; and (b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
n-BUTYL ALCOHOL
CAS 71-36-3 · EC 200-751-6
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: n-BUTYL ALCOHOL in preparations containing 10% or less of n-butyl alcohol except: (a) in preparations containing 5% or less of n-butyl alcohol; or (b) in preparations for cosmetic or therapeutic use other than spray form.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
n-BUTYL ALCOHOL
CAS 71-36-3 · EC 200-751-6
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: n-BUTYL ALCOHOL except: (a) when included in Schedule 5; or (b) in preparations containing 5% or less of n-butyl alcohol; or (c) in preparations for cosmetic or therapeutic use other than in spray form.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
n-PROPYL ALCOHOL
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 5.
Conditions: n-PROPYL ALCOHOL in preparations containing 10% or less of n-propyl alcohol except: (a) in preparations containing 5% or less of n-propyl alcohol; or (b) in preparations for cosmetic or therapeutic use other than in spray form.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 5 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
n-PROPYL ALCOHOL
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: n-PROPYL ALCOHOL except: (a) when included in Schedule 5; or (b) in preparations containing 5% or less of n-propyl alcohol; or (c) in preparations for cosmetic or therapeutic use other than in spray form.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
p- AMINOPHENOL
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: p- AMINOPHENOL except when used in hair dye and eyebrow/eyelash colouring products at a concentration of 1% or less of p-aminophenol after mixing for use when the immediate container and primary pack are labelled with the following statements: (a) KEEP OUT OF REACH OF CHILDREN; and (b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
p-METHYLAMINOPHENOL
CAS 150-75-4 · EC 205-768-2
The current Australian Poisons Standard places this cosmetic or personal-care use in Schedule 6.
Conditions: p-METHYLAMINOPHENOL except when used in hair dye and eyebrow/eyelash colouring products at a concentration of 1% or less of p-methylaminophenol after mixing for use when the immediate container and primary pack are labelled with the following statements: (a) KEEP OUT OF REACH OF CHILDREN; and (b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use; written in letters not less than 1.5 mm in height.
Source:Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, Schedule 6 · version Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 · effective June 1, 2026 · source checked 2026-08-31
Market coverage contract
Complete cosmetic-relevant Poisons Standard subset plus official workflow- Included scope
- All 125 current Schedule 2, 4, 5, 6 and 10 entries whose legal wording explicitly covers cosmetics or personal-care uses, plus AICIS verification links.
- If no match is found
- An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Complete verification checklist
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
Official sources and legal role
Australia AICIS Inventory
Industrial chemical identity, listing terms and assessment links
Legal meaning: Not an allowed/banned cosmetics list; use for per-CAS enrichment and source links
Available language: English
Australia Poisons Standard (SUSMP)
All current Poisons Standard entries whose source wording explicitly covers cosmetics or personal-care uses
Legal meaning: Binding Commonwealth scheduling instrument; state and territory implementation and AICIS duties still apply
Available language: English
Australia AICIS banned or restricted chemicals guidance
Official explanation of distributed Commonwealth, state and territory chemical controls
Legal meaning: Workflow guidance, not an exhaustive ingredient list
Available language: English
What this market page can answer
Source and authority
Identify the official material and the regulator responsible for it: Australian Industrial Chemicals Introduction Scheme.
Language and scope
See whether usable English or bilingual material exists and what the mapped source actually covers. Current source language: English.
Evidence status
Browse ingredient-level records imported from official sources. Each row states whether it passed deterministic source checks or human editorial review.
How to verify an ingredient for this market
- Search the ingredient by INCI name, CAS number or EC number and record the exact identity.
- Open each official source above and check the current version, product scope, concentration limits and required warnings.
- Confirm effective dates and whether an English text is official, reviewed or only contextual.
- Treat a missing local match as unknown, never as permission or a safety conclusion.